PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Cyclophosphamide ×

UPDATED
Regulatorische Updates
25. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA 088371 for Baxter Cyclophosphamide Injection
The FDA has approved ANDA 088371 for a cyclophosphamide injectable product (100 mg/vial) marketed by Baxter Healthcare, with multiple manufacturing and labeling submissions approved.